RESEARCH-USE BIOSIMILAR ANTIBODY
Tremelimumab
Monoclonal antibody · IgG2
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
TARGETCTLA4
YMonoclonal antibody
CATALOGSC-BS-082
CATALOG NUMBERSC-BS-082
MOLECULAR WEIGHTApprox. 146.38 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
Tremelimumab is a recombinant research-use antibody directed against CTLA4.